Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Delirium prior to dementia as a clinical phenotype of Lewy body disease: an autopsied case report

Fujishiro H, Kawakami I, Oshima K, Niizato K, Iritani S.

Int Psychogeriatr. 2017 Apr;29(4):687-689. doi: 10.1017/S1041610216001265. Epub 2016 Aug 16.

Comparison of force fields for Alzheimer's A β42: A case study for intrinsically disordered proteins

Carballo-Pacheco M, Strodel B.

Protein Sci. 2017 Feb;26(2):174-185. doi: 10.1002/pro.3064. Epub 2016 Oct 26.

[(18) F]AV-1451 tau positron emission tomography in progressive supranuclear palsy

Whitwell JL, Lowe VJ, Tosakulwong N, Weigand SD, Senjem ML, Schwarz CG, Spychalla AJ, Petersen RC, Jack CR Jr, Josephs KA.

Mov Disord. 2017 Jan;32(1):124-133. doi: 10.1002/mds.26834. Epub 2016 Oct 27.

Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View

Martin-Jiménez CA, Gaitán-Vaca DM, Echeverria V, González J, Barreto GE.

Mol Neurobiol. 2017 Nov;54(9):7096-7115. doi: 10.1007/s12035-016-0193-8. Epub 2016 Oct 28.

Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation

Galimberti D, Cioffi SM, Fenoglio C, Serpente M, Oblak AL, Rodriguez-Porcel F, Oldoni E, Hagen MC, Arcaro M, Scarpini E, Ghetti B, Espay AJ.

Mov Disord. 2017 Mar;32(3):476-478. doi: 10.1002/mds.26872. Epub 2016 Nov 15.

Aging of cerebral white matter

Liu H, Yang Y, Xia Y, Zhu W, Leak RK, Wei Z, Wang J, Hu X.

Ageing Res Rev. 2017 Mar;34:64-76. doi: 10.1016/j.arr.2016.11.006. Epub 2016 Nov 16.

Diagnosis of dementia with Lewy bodies: can (123)I-IMP and (123)I-MIBG scintigraphy yield new core features?

Sakamoto F, Shiraishi S, Tsuda N, Hashimoto M, Tomiguchi S, Ikeda M, Yamashita Y.

Br J Radiol. 2017 Feb;90(1070):20160156. doi: 10.1259/bjr.20160156. Epub 2016 Nov 29.

Comorbid conditions associated with Parkinson's disease: A longitudinal and comparative study with Alzheimer disease and control subjects

Santos García D, Suárez Castro E, Expósito I, de Deus T, Tuñas C, Aneiros A, López Fernández M, Núñez Arias D, Bermúdez Torres M.

J Neurol Sci. 2017 Feb 15;373:210-215. doi: 10.1016/j.jns.2016.12.046. Epub 2016 Dec 29.

Genetic counseling and testing for Huntington's disease: A historical review

Nance MA.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jan;174(1):75-92. doi: 10.1002/ajmg.b.32453. Epub 2016 May 13.

Mitochondrial Ca(2+) handling in Huntington's and Alzheimer's diseases - Role of ER-mitochondria crosstalk

Naia L, Ferreira IL, Ferreiro E, Rego AC.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1069-1077. doi: 10.1016/j.bbrc.2016.07.122. Epub 2016 Jul 30.

Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS)

Quaid KA, Eberly SW, Kayson-Rubin E, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators and Coordinators.

Clin Genet. 2017 Jun;91(6):824-831. doi: 10.1111/cge.12893. Epub 2016 Nov 24.

Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders

Di Domenico F, Tramutola A, Butterfield DA.

Free Radic Biol Med. 2017 Oct;111:253-261. doi: 10.1016/j.freeradbiomed.2016.10.490. Epub 2016 Oct 24.

Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?

Jodeiri Farshbaf M, Ghaedi K.

Biometals. 2017 Feb;30(1):1-16. doi: 10.1007/s10534-016-9981-x. Epub 2016 Nov 16.

Are microRNAs true sensors of ageing and cellular senescence?

Williams J, Smith F, Kumar S, Vijayan M, Reddy PH.

Ageing Res Rev. 2017 May;35:350-363. doi: 10.1016/j.arr.2016.11.008. Epub 2016 Nov 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias